Bullish Two Hundred Day Moving Average Cross - QCOR Wednesday, February 27, 4:58 PM ET, by Market News Video Staff In trading on Wednesday, shares of Questcor Pharmaceuticals Inc (QCOR) crossed above their 200 day ...
Land JAZZ Even Cheaper Than Its Secondary? Thursday, March 7, 12:08 PM ET, by Market News Video Staff Looking back to 2 days ago, Jazz Pharmaceuticals plc (JAZZ) priced a 5,375,000 share secondary ...
11.5% of XPH Holdings Seeing Recent Insider Buys Thursday, March 14, 10:29 AM ET, by Market News Video Staff A look at the weighted underlying holdings of the SPDR S&P Pharmaceuticals ETF (XPH) shows ...
In trading on Monday, shares of Medicis Pharmaceutical Corp. (MRX) crossed above their 200 day moving average of $35.31, changing hands as high as $35.44 per share. Medicis Pharmaceutical Corp. shares are currently trading up about 0.5% on the day. The chart below shows the one year performance of MRX shares, versus its 200 day moving average:
Looking at the chart above, MRX's low point in its 52 week range is $29.76 per share, with $40.10 as the 52 week high point — that compares with a last trade of $35.08.
According to the ETF Finder at ETF Channel, MRX makes up 4.05% of the SPDR S&P Pharmaceuticals ETF (AMEX:XPH) which is trading higher by about 1.9% on the day Monday.
This Article's Word Cloud:AboveAccordingCorpETFsFinderLookingManageManagementMedicisMondayMovingOfferPharmaceuticalPharmaceuticalsPortfolioRiskSPDRSpecialStartStocksTheiraboutaboveaveragebelowchangingchartcontaincrossedcurrentlyhandshighhighermovingotherperformancepointrangeraquoriskssharesharesshowsstockstradetradingtrialweekwhatwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
Now Playing:
Learn About The 200 DMA
Start slideshow:
Analyst Moves: DISH, MDR, PCLN
Analyst Moves: CRM, CRUS, MRVL
Daily Wrap: May 10, 2013
Daily Wrap: May 9, 2013
Daily Dividend Report: CRI, WM, CHRW, NVDA, CBI
Analyst Moves: MU, FRX, AES, CVC